Mystic Ventures

Mystic Ventures is a venture capital firm based in Florida, United States, specializing in early-stage investments at the intersection of biotechnology, artificial intelligence, and longevity. The firm focuses on addressing the mental health crisis by investing in innovative solutions within psychedelic medicine and consciousness expansion. Their investment thesis centers on the transformative potential of psychedelic therapies, precision neuromedicine, and machine learning to revolutionize mind-body optimization tools.

The firm's portfolio focus includes pharmaceuticals, clinical infrastructure, and digital therapeutics. Mystic Ventures seeks to empower exceptional teams developing novel compounds, therapeutic applications, and technology-enabled therapeutic experiences. By supporting these areas, the firm aims to build the future of mental healthcare through innovative solutions in psychedelic medicine and consciousness expansion technologies.

Founded in 2021, Mystic Ventures has made targeted investments in early-stage companies, with a notable investment in Xylo Bio's Seed VC - III round on May 31, 2024, amounting to $8 million. The firm's team comprises individuals with diverse backgrounds, including founder and managing partner Jeremy Gardner, who has experience in blockchain technology and social impact ventures, and investor relations lead Danny Kaufman, formerly the Director of Philanthropic Engagement for Burning Man. Their combined expertise positions Mystic Ventures as a leading funder in the emerging field of psychedelic medicine and consciousness expansion.